FDA Approved: ACITRETIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approves a supplemental application for Acitretin from Amneal Pharmaceuticals of New York LLC (ANDA 202552).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Acitretin (Acitretin)

Snippet

SUPPL AP for ACITRETIN (ACITRETIN)